Jerald Pelayo

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 8

Top Topics

Inferior Vena Cava

Glycemic Control

Top Venues

Expert review of cardiovascular therapy

BMJ case reports

Oxford medical case reports

The New England journal of medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jerald Pelayo, Anum Shahzad, Eric Peterson, Gregg Pressman
Platypnea-orthodeoxia syndrome in patent foramen ovale and fenestrated atrial septal aneurysm with normal right atrial pressure: what is the culprit? BMJ case reports 14 (7) (2021)
Jerald Pelayo, Kevin Bryan U Lo, Eric Peterson, Carly DeFaria, Atif Nehvi, Ricardo Torres, Muhammad Haisum Maqsood, Minaam Farooq, Roy O Mathew, Janani Rangaswami
Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with acute decompensated heart failure: a systematic review and meta-analysis. Expert review of cardiovascular therapy (2021)
Eduardo Quintero, Jerald Pelayo, Grace Salacup, Kevin Bryan Lo
Lupus enteritis as a lone manifestation of SLE: rare but possible. BMJ case reports 14 (8) (2021)
Asma Gulab, Ricardo Torres, Jerald Pelayo, Kevin Bryan U Lo, Anum Shahzad, Supriya Pradhan, Janani Rangaswami
Uric acid as a cardiorenal mediator: pathogenesis and mechanistic insights. Expert review of cardiovascular therapy 19 (6) (2021)
Jerald Pelayo, Kathleen Ruddiman
Miliary Tuberculosis. The New England journal of medicine 383 (12) (2020)
Jerald Pelayo, Gabriella Pugliese, Grace Salacup, Eduardo Quintero, Adeeb Khalifeh, David Jaspan, Bhavna Sharma
Severe COVID-19 in Third Trimester Pregnancy: Multidisciplinary Approach. Case reports in critical care 2020 (2020)
Jerald Pelayo, Naraharisetty Rau, Kevin Lo, Zurab Azmaiparashvili
Familial spontaneous pneumothorax and Machado-Joseph disease. Oxford medical case reports 2020 (9) (2020)
Kevin Bryan U Lo, Ruchika Bhargav, Grace Salacup, Jerald Pelayo, Jeri Albano, Peter A McCullough, Janani Rangaswami
Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with COVID-19: a systematic review and meta-analysis. Expert review of cardiovascular therapy 18 (12) (2020)